Anchen Pharmaceuticals, Inc clinical trials
Acquired by Par Health, Nov 10, 2025 · source ↗
The registry lists 2 studies whose lead sponsor is Anchen Pharmaceuticals, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 12, 2012.
Before and after it joined Par Health
- First submitted before Anchen Pharmaceuticals, Inc became part of Par Health
- 2
- First submitted after Anchen Pharmaceuticals, Inc became part of Par Health
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Anchen Pharmaceuticals, Inc2 studies
Something wrong with this grouping? Tell us on the Par Health page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Par Health studies →
- Evaluation of Clinical Equivalence Between Two Lubiprostone ProductsCompletedNCT01372423Phase 3
Sponsor listed in the registry: Anchen Pharmaceuticals, Inc · First submitted before Anchen Pharmaceuticals, Inc became part of Par Health
- Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%CompletedNCT01456611Phase 3
Sponsor listed in the registry: Anchen Pharmaceuticals, Inc · First submitted before Anchen Pharmaceuticals, Inc became part of Par Health